Literature DB >> 7637018

A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4.

R E Bachelder1, J Bilancieri, W Lin, N L Letvin.   

Abstract

To explore the role of the CD4 molecule in human immunodeficiency virus (HIV) infection following initial virus-CD4 binding, we have characterized CD4-specific antibodies raised by immunizing an HIV-1-infected human with human recombinant soluble CD4 (rsCD4). Fabs were selected from a human recombinant Fab library constructed from the bone marrow of this immunized individual. Here, we describe a human rsCD4-specific recombinant Fab clone selected by panning the library over complexes of human rsCD4 and recombinant HIV-1 envelope protein. While this Fab does not bind to CD4-positive T-cell lines or to human T lymphocytes, it recognizes cell surface-expressed CD4 following the incubation of these cells with a recombinant form of HIV-1 gp120 or with HIV-1 virions. The Fab is not HIV-1 envelope specific, since it does not bind to recombinant gp120 or to native cell surface-expressed HIV-1 envelope proteins. As confirmation of its CD4 specificity, we show that this Fab immunoprecipitates a 55-kDa protein, corresponding to the molecular mass of cellular CD4, from an H9 cell lysate. The specificity of this human Fab provides evidence for a virus-induced conformational change in cell surface-expressed on CD4. The characterization of this altered CD4 conformation and its effects on the host cell will be important in defining postbinding events in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637018      PMCID: PMC189434     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals.

Authors:  P D Kwong; S E Ryu; W A Hendrickson; R Axel; R M Sweet; G Folena-Wasserman; P Hensley; R W Sweet
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Identification of the residues in human CD4 critical for the binding of HIV.

Authors:  J Arthos; K C Deen; M A Chaikin; J A Fornwald; G Sathe; Q J Sattentau; P R Clapham; R A Weiss; J S McDougal; C Pietropaolo
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

3.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation.

Authors:  C H Heldin; A Ernlund; C Rorsman; L Rönnstrand
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

4.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants.

Authors:  E Helseth; M Kowalski; D Gabuzda; U Olshevsky; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.

Authors:  P Portoles; J Rojo; A Golby; M Bonneville; S Gromkowski; L Greenbaum; C A Janeway; D B Murphy; K Bottomly
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

7.  Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.

Authors:  M Kowalski; B Ardman; L Basiripour; Y C Lu; D Blohm; W Haseltine; J Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells.

Authors:  M Benkirane; K T Jeang; C Devaux
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.

Authors:  F Celada; C Cambiaggi; J Maccari; S Burastero; T Gregory; E Patzer; J Porter; C McDanal; T Matthews
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  6 in total

1.  A chimeric protein of simian immunodeficiency virus envelope glycoprotein gp140 and Escherichia coli aspartate transcarbamoylase.

Authors:  Bing Chen; Yifan Cheng; Lesley Calder; Stephen C Harrison; Ellis L Reinherz; John J Skehel; Don C Wiley
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Reduced monomeric CD4 is the preferred receptor for HIV.

Authors:  Lisa J Matthias; Iman Azimi; Catherine A Tabrett; Philip J Hogg
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

3.  Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion.

Authors:  Kelly Huang; Len Incognito; Xing Cheng; Nancy D Ulbrandt; Herren Wu
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

4.  Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerization.

Authors:  Nichole Cerutti; Mark Killick; Vinesh Jugnarain; Maria Papathanasopoulos; Alexio Capovilla
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

5.  The Role of the Charged Residues of the GP2 Helical Regions in Ebola Entry().

Authors:  Haiqing Jiang; Jizhen Wang; Balaji Manicassamy; Santhakumar Manicassamy; Michael Caffrey; Lijun Rong
Journal:  Virol Sin       Date:  2009-04       Impact factor: 4.327

6.  Screening of human antibody Fab fragment against HBsAg and the construction of its dsFv form.

Authors:  Leili Jia; Jiyun Yu; Hongbin Song; Xuelin Liu; Weina Ma; Yuanyong Xu; Chuanfu Zhang; Shicun Dong; Qiao Li
Journal:  Int J Biol Sci       Date:  2008-04-24       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.